The level of DNMT-1 mRNA was significantly lower in atopic patients compared to controls (P<0.01). There was a significant negative correlation between DNMT-1 mRNA expression and IL-13 mRNA expression in both AD groups ( r=-0.712 
I. Introduction
Atopic dermatitis (AD) is a chronic inflammatory fluctuating pruritic skin disease in which hereditary, environmental and immunological factors play a major role. Its clinical presentation varies from acute eczematous eruption in early life to a characteristic lichenified dermatitis in older patients [1] [2] [3] . The chronicity of AD intensely affects the quality of life of patients and their families. Its diagnosis is usually based on clinical criteria and lacks the laboratory evidence that can confirm or rule out its existence 4 . The pathogenesis of AD is multifactorial including the differentiation of helper T cells, pattern of local cytokine expression, multiple role for IgE, infectious agents, and super antigens 5 . The aetiology of AD as an IgE-mediated disorder is complex and still not completely understood. IgE contributes to the inflammatory cell infiltrate in AD by several mechanisms, including a biphasic immediate/ late phase reaction, allergic presentation of IgE-bearing langerhans cells, allergen-induced activation of IgE-bearing macrophages, and IgE auto reactivity to human proteins 5 . IL-13 is an immunoregulatory cytokine generated predominately by activated Th2 cells and it shares many functional properties with IL-4 6 . Similar to IL-4, IL-13 induces Ig class switching and IgE secretion, upregulates the expression of MHC class II molecules and the low affinity receptor for IgE (CD23) on B cells and induces the expression of VCAM-1 on endothelium 7 . IgE productions by B cells depends mainly on secreted IL-13, and to a lesser extend, on IL-4 of cutaneous lymphocyte-associated antigen (CLA)+ memory T cells. Accordingly, IL-13 produced by the skin selective homing T cells in high amount may have an important role in the pathogenesis of AD 8 . DNA methylation is known to play an important role in gene transcription and alterations of methylation can contribute to the development of certain disorders such as autoimmune diseases 9 . Hypomethylation has been considered to be related to hyperresponsiveness against autoantigens and exogenous antigen in certain autoimmune diseases as well as in allergic disorders 10 . For DNA methylation in mammalian Expression of mRNA for IL-13 and DNMT-1 in patients with Atopic Dermatitis www.iosrjournals.orgcells, DNA methyltransferase -1 (DNMT-1); one of the essential member of this family is supposed to be responsible for the promotion of gene methylation 11 . The aim of this work is to study IL-13 mRNA and DNMT-1 mRNA expression in peripheral blood in patients with different degrees of AD in order to evaluate their role in the pathogenesis of the disease and to correlate their profile with the serum level of IgE and with the clinical severity of the disease.
II. Patients and Methods
This study included 15 patients with AD; 9 males and 6 females; selected from Outpatient Clinics of Dermatology and Venereology and Paediatrics of Al Zahraa University Hospital during the period from October 2009 to April 2010. Their ages ranged from 1-16 years.
Fifteen healthy volunteers were chosen as controls. They were 8 males and 7 females. Their ages ranged from 3-14 years. None of them had a history of skin or systemic disease.
The patients were not receiving systemic treatment for the present conditions for at least 4 weeks before enrollment in the study and no topical treatment for at least 2 weeks. Thorough history, especially the family history of atopic dermatitis was taken. History and clinical examination were done to detect other atopic manifestations. All patients fulfilled the diagnostic criteria of Hanifin and Rajka 12 . The disease severity was assessed using the Nottingham Eczema Severity Score (NESS) 13 . The patients were classified according to NESS into three groups: Group A: Mild cases (3 AD patients with NESS total score 3-8), Group B: Moderate cases (4 AD patients with NESS total score 9-11), Group C: Severe cases (8 AD patients with NESS total score 12-15). For statistical issue as the numbers of the patients in mild and moderate groups are small they are gathered in a group termed mild-moderate. An informed written consent was obtained from the subjects or their legal guardians before their contribution in this study.
III. Methods
Five ml of venous blood were withdrawn from each subject and divided into two portions, the first portion 2 ml used for estimation of total IgE level, serum samples were obtained after clotting and centrifugation of blood and stored at -20 O C until the time of IgE assay IgE was assayed by Immulite 1000 systems (chemiluminescence method) using kit supplied by Siemens Health-care Diagnostics products Ltd ( united kingdom). IgE is a solid phase, two-site chemiluminesent immunometric assay. The solid phase is a polystyrene bead enclosed within a test unit containing the coated bead. An alkaline phosphatase conjugated to polyclonal goat anti IgE is also added to the test unit. After the wash and incubation steps, chemiluminescent substrate undergoes hydrolysis in the presence of alkaline phosphatase. The photon output as measured by the luminometer is related to the presence of IgE in the sample).
The second portion, 3 ml of venous blood was added to Heparin and mixed well and then put over tube containing 6 ml Ficoll-hypaque density gradient solution. (Biowaltker -Germany). The mononuclear cells (PBMC) were obtained by centrifugation at 1200 rpm for 20min. in a cooling centrifuge at 4 ºC. Then the Buffy coat ring of mononuclear cells were aspirated at the interface and carefully transferred with Pasteur pipette and washed twice with HBSS (hank's salt balanced solution) using the cooling centrifuge for 20 min at 1200 rpm, then after the bellet of cells is suspended in a least amount of phosphate buffer saline (PBS) then subject it to the extraction procedure.
A -RNA extraction:
The extraction of mRNA from PBMC were performed according to QIAGEN (QIA amp) Spin column mRNA extraction kit (QIA gen Inc, Germany) catalog number 52904. 570 µl of lysis reagent + 200 µl of cell sustention were dispensed in a sterile eppendorf tube ( RNAse, DNAse free ) and then incubated for one hour at 65 o c ºC . 570 µl of absolute ethanol were added and then transferred to the column and spin at 8000 rpm for one minute. 500 µl of wash I was dispended then the tube was spin for one minute at 8000 rpm. 500 µl of wash II was dispended then the tube was spin for 3 min at 1400 rpm. Then dispense 80 µl of elution buffer and stay at room temp for 5 min. The tube was centrifuged for one minute at 8000 rpm, giving a final volume of 80 µl of purified RNA. The selected primer (Invitrogen) for DNMT1 mRNA was the following sequence Forward: 5'-CCTAGTTCCGTGGCTACGAGGAGAA-3' Reverse: 5'-TCTCTCTCCTCTGCAGCCGACTCA-3' And the Primer sequence for IL-13 mRNA was (Invitrogen), Forward: 5'-TGAGGAGCTGGTCAACATCA-3' Reverse: 5-'CAGGTTGATGCTCCATACCAT-3' The Applied Biosystems taqman PCR MMX kit was used with 10 template in a final volume of 25 µl Gylceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as input control. The primer sequence (Invitrogen) of GAPDH was as follow: Forward: 5'-TTCCAGGAGCGAGATCCCT-3' Reverse: 5'-CACCCATGACGAACATGGG-3' 16S rRNA standard with known conc. is used to establish a standard curve as a reference for quantifying the results.Statistical Analysis:-
The statistical analysis of data was done by using statistical package for social science (SPSS) version 16 on windows XP.
The description of data was done as frequency and proportion for qualitative data mean ± SD for quantitative data. The analysis of data was done to test statistical significant difference for quantitative data using student's t test. For qualitative data [frequency & proportion] chi-square test was used. Measuring the mutual correspondence between two values was done using the pearson's correlation coefficient. P value was considered significant if  0.05 at confidence interval of 95% 14 .
IV. Results
The present study included 15 patients with AD and 15 healthy age and sex matched controls. The patients were 9 males and 6 females. Their aged ranged from 1-16 years with a mean of 7.40 ± 4.73. They gave no past or present history of any other cutaneous or systemic disease. Eight patients had family history of atopy, 6 patients had a history of recurrent bronchial asthma. None of these patients had been receiving systemic steroids for at least 2 months before the study. Serum level of IgE was statistically significantly higher in atopic patients than in control group (P<0.01). Also IL-13 mRNA showed statistically significant positive expression in patients with atopic dermatitis as compared to control group(P<0.01)while DNMT-1 mRNA showed statistically significant negative expression in patients with atopic dermatitis (P<0.01) as compared to control group (Table1). When comparing serum level of IgE in mild -moderate atopic patients to control group , there was significant increase in serum level of IgE in mild -moderate atopic patients than in control group (P<0.01). Also the expression of IL-13 mRNA was significantly higher in mild -moderate atopic patients than in controls (P<0.01) while the expression of DNMT-1 mRNA was significantly lower in mild -moderate atopic patients compared to controls (P<0.01 ) ( Table 2 ).
When comparing the serum level of IgE, the expression of IL-13 mRNA and DNMT-1 mRNA in severe cases of atopic dermatitis and controls, there was significant increase in both serum level of IgE and expression of IL-13 mRNA and significant decrease in DNMT-1 expression in severe form atopic patients compared to control group (P <0.01) ( Table 3) .
On comparing IgE level, IL-13 mRNA and DNMT-1 mRNA expression in severe and mild -moderate groups of AD,there was no significant difference in serum level of IgE in both groups (p>0.05) while there was a statistically significant increase IL-13 mRNA expression and statistically significant decrease in DNMT-1 mRNA expression in severe form of AD group when compared to mild -moderate AD group (P <0.01) ( Table  4) .
A statistically significant positive correlation was found between IL-13 mRNA expression and serum level of IgE (P≤0.05,r=0.616) and statistically significant negative correlation was found between DNMT-1 mRNA expression and serum level of IgE (P ≤ 0.05,r=-0.712). Also we found statistically significant negative correlation between IL-13 mRNA expression and DNMT-1 mRNA expression (P≤ 0.01,r=-0.868)in all atopic dermatitis patients A statistically significant positive correlation was found between IL-13 mRNA expression and NESS score (P< 0.01, r= 0.805) and statistically significant negative correlation between DNMT-1 mRNA expression and NESS score (P< 0.01, r= -0.961) (Table5). 
V. Discussion
Atopic dermatitis is a multifactorial genetically based disease that affects 10-15% of children in many parts of the world and constitutes a significant burden to patients and their families 4 . It is frequently seen in children with history of respiratory allergy and/ or family history of atopic disease 15 . Over all, atopy is familial hypersensitivity of skin and mucous membranes against environmental substances which is associated with increased IgE production 5 . In the present study 6 patients had personal history and 8 patients had family history of atopic disease and this agreed with Hanifin and chan 16 , who reported that most but not all persons with AD have a personal or family history of allergic rhinitis or asthma. Atopic dermatitis patients had significant elevation of serum IgE as compared to normal controls. This was in agreement with leung and Soter 5 who reported that only a small sub group < 30% of atopic patients had a normal level of IgE. Atopy is associated with local infiltration of Th2 cells. Th2 cytokines play an important role in immune modulation of inflammatory diseases. It is hypothesized that several cytokines including IL-4, IL-5 and IL-13 are released from these cells 17 . IL-5 is a prominent Th2 cytokine that has important roles in immune modulation of inflammatory disease 7 . IL-4 and IL-13 induce immunoglobulin class switching and IgE secretion, upregulate the expression of MHC class II molecules and the low affinity receptor for IgE on B cells. These data suggest that IL-13 is a crucial mediator of immune diseases, especially in atopic state 18 . Previous studies reported that this cytokine is significantly expressed in chronic lichenified lesion of AD patients than in the skin of healthy controls 5, 19 . IL-13 mRNA expression was also detected by RT-PCR in lesional and non lesional skin and PBMC from AD patients, but not in normal skin or PBMC from healthy control 20 . Present findings showed highly significant increase in expression of IL-13 mRNA in patients with different degrees of AD as compared to normal controls. This was in agreement with katagiri et al 21 and Metwally et al 22 who found increased levels of IL-13 mRNA expression in PBMC in patients with AD. Obara et al 20 reported that IL-13 may play a local as well as a systemic role in the development of AD lesions. We also found that in more sever cases there was increase in the degree of expression of IL-13 mRNA and this was in agreement with Metwally et al 22 . Our results revealed statistically significant positive correlation between IL-13 mRNA expression and clinical severity of this disease and this is in agreement with that of Koning et al 24 22 who reported that patients having increase in IL-13 had higher serum IgE levels than those with normal IL-13 level , suggesting a direct association between serum levels of IL-13 and IgE.
Contrary to our results, Van Der Ploeg et al 19 found no correlation between serum IgE levels and gene expression in the chronic lichenified lesions and they suggested that cells other than Th2 cells might be involved in IL-13 gene expression and maintenance of the disease. This controversy may be related to difference in IL-13 expression in blood from the skin.
DNA hypomethylation is supposed to promote hyperreactivity of Th2 cells to allergens and the resultant cytokine-mediated production of IgE. In fact, some reports have also suggested that IL-4 mediated production of IgE in patients with high serum levels is related to DNA hypomethylation in B cells 27, 28 . A previous study reported that IL-13 expression in Th2 cells is regulated by the methylation status of a region in the proximal promoter encompassing three Putative GATA -3 binding sites 29 .
In this study we demonstrated that the expression of DNMT-1 mRNA was significantly lower in patients with different degrees of AD as compared to normal controls. And also statistically significant negative correlation was found between serum level of IgE and DNMT-1 mRNA expression. Nakamura et al 9 in his study classify the AD patients into 2 groups; group A with high level of IgE who showed significant lower level of DNMT-1 mRNA expression compared to controls and supported the concept that the onset of AD is promoted by lower levels of DNMT-1 and group B with lower level of IgE also showed lower level of DNMT-1 mRNA expression compared to controls but without a statistically significant difference. Also he reported that there was no statistical significant difference of the DNMT-1 mRNA level between group A and B patients indicating that DNMT-1 may not be a factor solely influencing serum IgE. To clarify this issue, the studies such as evaluating the DNMT-1 levels in non-AD patients with high serum level of IgE would be necessary.
Several reports have suggested that DNA hypomethylation (especially in T cells) may contribute to the development of autoreactive cells in SLE 30 patients. Low DNMT-1 activity in SLE patients has also been suggested to relate to hyperresponsiveness to exogenous antigens (such as infectious agents) in addition to autoantigens. The fact that SLE patients are known to have a higher frequency of IgE-mediated allergic diseases (including AD) in their family history suggests certain similarities in both diseases, such as hyerresponsiveness to autoantigens and/ or exogenous antigens resulted from low DNMT-1 expression 31 . The present study showed significant negative correlation between IL-13 mRNA and DNMT-1 mRNA expression in patient group. DNA methylation modifies gene expression through at least three mechanisms. Methylation of target sequences prevents the binding of some transcriptional activators, such as Sp1 and AP-2, thereby suppressing expression 32 . Methylated binding proteins can also prevent the binding of transcription factors and can suppress gene expression from a distance 33 . Methylated binding proteins also attract chromatin remodeling complexes that modify adjacent histones, resulting in a condensed nucleosome structure, making the locus inaccessible to transcription factors 34 . Moreover , it has been demonstrated that the expression of cytokine genes during T-cell differentiation is regulated by acetylation and methylationdependent chromatin structural changes 35 . It can be concluded that (1) IL-13 seems to be important in the pathogenesis of AD, the differences in IL-13 expression between groups indicates the association correlation of IL-13 with the severity of AD. The relation of IL-13 with IgE may indicate that IL-13 is responsible for regulating the in vivo synthesis of IgE in patients with AD.
(2) Disease activity-related increase of IL-13 expression is associated with demethylation of DNA. These findings may provide a basis for the design of a new therapy aimed at reversing the epigenetic alterations of gene expression in AD patients.
